Table 3:

Clinical course and outcome

No Vessel Enhancement within Hematoma, Suspect ICH (n=41)Vessel Enhancement within Hematoma, Suspect ISH (n=30)RR, No Vessel Enhancement (Suspect ICH)
Condition on admission
    Good (WFNS I-III)16 (40%)14 (50%)
    Poor (WFNS IV-V)24 (60%)14 (50%)1.2 (95% CI, 0.8–1.8)
    Not assessablea12
Focal deficits
    None9 (29%)10 (41%)
    Present22 (71%)14 (58%)1.2 (95% CI, 0.8–1.9)
    Hemiparesis95
    Dysphasia33
    Other106
    Not assessableb106
Day of discharge
    Mean (range)18 (0–92)26 (0–149)
    Median1719
Discharge destination
    Nursing home2 (4.9%)3 (10.0%)
    Rehabilitation center4 (9.8%)4 (13.3%)
    Other hospital10 (24.4%)6 (20.0%)
    Home6 (14.6%)5 (16.7%)
    Death19 (46.3%)12 (40.0%)1.2 (95% CI, 0.7–2.0)
Outcome, 3 months
    Poor (GOS ≤3)26 (65%)17 (63%)1.0 (95% CI, 0.7–1.5)
    Good (GOS >3)14 (35%)7 (37%)
    Unknown13
  • a Evaluation of coma score not possible as a result of sedation.

  • b Evaluation of focal deficits not possible as a result of poor clinical status.